Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,633 | 275 | 50.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,500 | 4 | 49.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Depomed, Inc. | $7,013 | 19 | $0 (2017) |
| Nevro Corp. | $720.96 | 17 | $0 (2024) |
| Medtronic, Inc. | $689.23 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $488.21 | 29 | $0 (2024) |
| Forte Bio-Pharma LLC | $441.20 | 8 | $0 (2024) |
| GRT US Holding, Inc. | $297.73 | 14 | $0 (2022) |
| Virtus Pharmaceuticals LLC | $277.42 | 20 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $243.39 | 15 | $0 (2024) |
| Horizon Pharma plc | $235.14 | 17 | $0 (2018) |
| MEDACTA USA, INC. | $208.85 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,614 | 54 | Medtronic, Inc. ($505.59) |
| 2023 | $710.96 | 23 | Abbott Laboratories ($139.52) |
| 2022 | $628.19 | 27 | Kowa Pharmaceuticals America, Inc. ($168.42) |
| 2021 | $723.23 | 34 | GRT US Holding, Inc. ($217.12) |
| 2020 | $372.18 | 14 | Forte Bio-Pharma LLC ($147.02) |
| 2019 | $1,179 | 54 | MEDACTA USA, INC. ($208.85) |
| 2018 | $567.30 | 29 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($167.76) |
| 2017 | $7,338 | 44 | Depomed, Inc. ($7,013) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 12/11/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: ORTHOPEDICS | ||||||
| 12/11/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 12/03/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 11/22/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 11/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $43.91 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/01/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 10/24/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/09/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/08/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 09/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/05/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $43.25 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/30/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 08/28/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: PAIN | ||||||
| 08/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $151.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/19/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 07/12/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: ANALGESICS - OPIOID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,255 | 2,778 | $880,372 | $166,782 |
| 2022 | 33 | 1,381 | 2,948 | $887,979 | $168,751 |
| 2021 | 33 | 1,997 | 3,713 | $1.5M | $220,093 |
| 2020 | 32 | 1,842 | 4,362 | $1.5M | $186,714 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 542 | $200,540 | $48,910 | 24.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 88 | 129 | $218,325 | $31,929 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 209 | $52,877 | $13,809 | 26.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 47 | 56 | $68,904 | $11,057 | 16.0% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 32 | 46 | $39,928 | $9,192 | 23.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $28,120 | $6,318 | 22.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 198 | 1,112 | $26,688 | $5,703 | 21.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 42 | 48 | $29,853 | $5,126 | 17.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 35 | 39 | $13,206 | $3,406 | 25.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 28 | 40 | $13,948 | $3,345 | 24.0% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 32 | 32 | $43,602 | $3,281 | 7.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $14,586 | $3,213 | 22.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 14 | 14 | $22,653 | $3,130 | 13.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 21 | 31 | $15,456 | $2,790 | 18.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 29 | 31 | $11,988 | $2,238 | 18.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 37 | 42 | $11,050 | $2,131 | 19.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 12 | 15 | $13,266 | $2,087 | 15.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 12 | 12 | $9,600 | $2,037 | 21.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 69 | 70 | $8,750 | $1,845 | 21.1% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 14 | 14 | $17,038 | $1,145 | 6.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 13 | 17 | $5,850 | $1,009 | 17.3% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 22 | 22 | $2,750 | $641.20 | 23.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 14 | 17 | $3,230 | $639.00 | 19.8% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 16 | 19 | $2,413 | $525.60 | 21.8% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 12 | 12 | $1,752 | $417.67 | 23.8% |
About Dr. William Lichtenfeld, M.D
Dr. William Lichtenfeld, M.D is a Pain Medicine healthcare provider based in Johns Creek, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164422572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Lichtenfeld, M.D has received a total of $13,133 in payments from pharmaceutical and medical device companies, with $1,614 received in 2024. These payments were reported across 279 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,633).
As a Medicare-enrolled provider, Lichtenfeld has provided services to 6,475 Medicare beneficiaries, totaling 13,801 services with total Medicare billing of $742,340. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Johns Creek, GA
- Active Since 07/28/2005
- Last Updated 06/03/2014
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1164422572
Products in Payments
- Nucynta (Drug) $7,013
- INTELLIS ADAPTIVESTIM (Device) $595.40
- RELISTOR (Drug) $460.23
- Senza (Device) $452.76
- Qutenza (Drug) $297.73
- LEVORPHANOL TARTRATE (Drug) $277.42
- MYSPINE (Device) $208.85
- PROLATE (Drug) $198.07
- Senza Spinal Cord Stimulation System (Device) $194.53
- XTAMPZA (Drug) $180.91
- Seglentis (Drug) $168.42
- Nalocet (Drug) $160.92
- Prospera (Device) $156.12
- DUEXIS (Drug) $147.86
- PROCLAIM (Device) $139.52
- BELBUCA (Drug) $133.00
- LORZONE (Drug) $120.26
- ORTHOVISC (Device) $119.35
- Levorphanol Tartrate (Drug) $113.33
- COOLIEF (Device) $102.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.